Summary:
We are currently conducting a study evaluating the safety and effectiveness of a Chinese herb (botanical product) for Ulcerative Colitis.
This is a double-blind placebo controlled trial.
The study herb has been tested/used in over 129 million users. Previous studies show it inhibits inflammation and reduces colon damage similar to the drug mesalamine.
Qualified Participants Must:
• Have active mild to moderate ulcerative colitis
•
Be at least 18 years of age
•
Subjects may be on a stable dose of oral Mesalamine
•
Be able to attend up to seven (7) study visits over the up to 12 week study
Qualified Participants May Receive:
Study related medical, laboratory and colonoscopy exams at no cost. Study medication provided at no cost. Time and travel compensation of $25.00 per visit completed.